¼¼°èÀÇ »ý¸í°úÇÐ ºÐ¾ß »ý¼ºÇü AI ½ÃÀå(2025-2029³â)
Global Generative AI in Life Sciences Market 2025-2029
»óǰÄÚµå : 1783889
¸®¼­Ä¡»ç : TechNavio
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 224 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,500 £Ü 3,513,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,000 £Ü 5,622,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

»ý¸í°úÇÐ »ý¼ºÇü AI ½ÃÀåÀº 2024-2029³â¿¡ 10¾ï 5,580¸¸ ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø ±â°£ Áß ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 20.3%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º» º¸°í¼­´Â »ý¸í°úÇÐ ºÐ¾ß »ý¼ºÇü AI ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´ë»óÀ¸·Î ÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.

ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ¼ºÀå¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº ¿¬±¸ °³¹ßÀÇ È¿À²È­, ´ë·® ¹× ¸ÖƼ¸ð´Þ »ý¹°ÇÐÀû µ¥ÀÌÅÍÀÇ È®»ê, ±â¹Ý AI ¹× ÄÄÇ»ÆÃ ÀÎÇÁ¶óÀÇ ¹ßÀü¿¡ ÈûÀÔ¾î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
±âÁØ ¿¬µµ 2025³â
Á¾·á ¿¬µµ 2029³â
¿¹Ãø ±â°£ 2025-2029³â
¼ºÀå ¸ð¸àÅÒ °¡¼Ó
Àü³â´ëºñ 18.1%
CAGR 20.3%
Áõ°¡¾× 10¾ï 5,580¸¸ ´Þ·¯

º» Á¶»ç´Â ¾÷°è ÁÖ¿ä Âü¿©ÀÚµéÀÇ ÀǰßÀ» Æ÷ÇÔÇÏ¿© 1Â÷ Á¤º¸¿Í 2Â÷ Á¤º¸¸¦ °´°üÀûÀ¸·Î Á¶ÇÕÇÏ¿© ½Ç½ÃµÇ¾ú½À´Ï´Ù. ÀÌ º¸°í¼­¿¡´Â ÁÖ¿ä ±â¾÷ ºÐ¼®°ú ÇÔ²² Á¾ÇÕÀûÀÎ ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ªº° ºÐ¼®¿¡ µû¸¥ ºÎ¹®, °ø±Þ¾÷ü ÇöȲÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. º¸°í¼­¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÇâÈÄ ¸î ³â µ¿¾È »ý¸í°úÇÐ ºÐ¾ß »ý¼ºÇü AI ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ ÁÖ¿ä ¿äÀÎ Áß Çϳª·Î ÅëÇÕÇü Æó¼âÇü ·çÇÁ Ž»ö Ç÷§ÆûÀÇ ÃâÇöÀ» ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ, »ý¹°Çп¡ ´ëÇÑ ´ë±Ô¸ð ±â¹Ý ¸ðµ¨ °³¹ß ¹× Ž»ö¿¡¼­ ÀÓ»ó ¹× ±ÔÁ¦ ¿ëµµ·ÎÀÇ È®´ë´Â ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä

Á¦2Àå Technavio ºÐ¼®

  • °¡°Ý, ¼ö¸íÁÖ±â, °í°´ ±¸ÀÔ ¹Ù½ºÄÏ, äÅà ºñÀ², ±¸ÀÔ ±âÁØ ºÐ¼®
  • ÀÎDzÀÇ Á߿伺°ú Â÷º°È­ ¿äÀÎ
  • È¥¶õ ¿äÀÎ
  • ¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ

Á¦3Àå ½ÃÀå ±¸µµ

  • ½ÃÀå »ýŰè
  • ½ÃÀå Æ¯Â¡
  • ¹ë·ùüÀÎ ºÐ¼®

Á¦4Àå ½ÃÀå ±Ô¸ð

  • ½ÃÀåÀÇ Á¤ÀÇ
  • ½ÃÀå ºÎ¹® ºÐ¼®
  • ½ÃÀå ±Ô¸ð(2024³â)
  • ½ÃÀå Àü¸Á(2024-2029³â)

Á¦5Àå Five Forces ºÐ¼®

  • Five Forces ¿ä¾à
  • ¹ÙÀ̾îÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù
  • °æÀï À§Çù
  • ½ÃÀå ÇöȲ

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­ : ¿ëµµº°

  • ½ÃÀå ºÎ¹®
  • ºñ±³ : ¿ëµµº°
  • Drug Discovery : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • ¸ÂÃãÇü ÀÇ·á : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • ÀÓ»ó½ÃÇè : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • ½ÃÀå ±âȸ : ¿ëµµº°

Á¦7Àå ½ÃÀå ¼¼ºÐÈ­ : ±â¼úº°

  • ½ÃÀå ºÎ¹®
  • ºñ±³ : ±â¼úº°
  • »õ·Î¿î ºÐÀÚ »ý¼º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • ´Ü¹éÁú ¹è¿­ ¼³°è : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • ÇÕ¼º À¯ÀüÀÚ ¼³°è : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • ½ÃÀå ±âȸ : ±â¼úº°

Á¦8Àå ½ÃÀå ¼¼ºÐÈ­ : Àü°³ Çüź°

  • ½ÃÀå ºÎ¹®
  • ºñ±³ : Àü°³ Çüź°
  • Ŭ¶ó¿ìµå ±â¹Ý : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • On-Premise : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • ÇÏÀ̺긮µå : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • ½ÃÀå ±âȸ : Àü°³ Çüź°

Á¦9Àå °í°´ »óȲ

  • °í°´ »óȲ °³¿ä

Á¦10Àå Áö¿ªº° »óȲ

  • Áö¿ªº° ¼¼ºÐÈ­
  • Áö¿ªº° ºñ±³
  • ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • ¾Æ½Ã¾ÆÅÂÆò¾ç : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • ³²¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • ¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • ¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • ¸ß½ÃÄÚ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • Àεµ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • ³×´ú¶õµå : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2029³â)
  • ½ÃÀå ±âȸ : Áö¿ª »óȲº°

Á¦11Àå ¼ºÀå, ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ ¹× ¼ºÀå ¾ïÁ¦¿äÀÎ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
  • ¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
  • ½ÃÀå ±âȸ¿Í ¼ºÀå ¾ïÁ¦¿äÀÎ

Á¦12Àå °æÀï ±¸µµ

  • °³¿ä
  • °æÀï ±¸µµ
  • ÆÄ±«Àû Çõ½Å »óȲ
  • ¾÷°è ¸®½ºÅ©

Á¦13Àå °æÀï ºÐ¼®

  • ±â¾÷ °³¿ä
  • ±â¾÷ ¼øÀ§ Áö¼ö
  • ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
  • AiCure
  • Atomwise Inc.
  • BenevolentAI
  • Boehringer Ingelheim International GmbH
  • Google LLC
  • Insilico Medicine
  • International Business Machines Corp.
  • Microsoft Corp.
  • NVIDIA Corp.
  • Owkin Inc.
  • PathAI Inc.
  • Recursion Pharmaceuticals Inc.
  • Sanofi SA
  • Schrodinger Inc.
  • SOPHiA GENETICS

Á¦14Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The generative AI in life sciences market is forecasted to grow by USD 1,055.8 mn during 2024-2029, accelerating at a CAGR of 20.3% during the forecast period. The report on the generative AI in life sciences market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by imperative to enhance research and development efficiency, proliferation of high volume, multimodal biological data, and advancements in foundational AI and computing infrastructure.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 202518.1%
CAGR20.3%
Incremental Value$1,055.8 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's generative AI in life sciences market is segmented as below:

By Application

By Technology

By Deployment

By Geographical Landscape

This study identifies the emergence of integrated, closed-loop discovery platforms as one of the prime reasons driving the generative AI in life sciences market growth during the next few years. Also, development of large foundational models for biology and expansion beyond discovery into clinical and regulatory applications will lead to sizable demand in the market.

The report on the generative AI in life sciences market covers the following areas:

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading generative AI in life sciences market vendors that include AiCure, Atomwise Inc., BenevolentAI, Boehringer Ingelheim International GmbH, Clarivate PLC, Evogene Ltd., Fujitsu Ltd., Google LLC, Insilico Medicine, International Business Machines Corp., Microsoft Corp., NVIDIA Corp., Owkin Inc., PathAI Inc., Recursion Pharmaceuticals Inc., Sanofi SA, Schrodinger Inc., SOPHiA GENETICS, and Tencent Holdings Ltd.. Also, the generative AI in life sciences market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Five Forces Analysis

6 Market Segmentation by Application

7 Market Segmentation by Technology

8 Market Segmentation by Deployment

9 Customer Landscape

10 Geographic Landscape

11 Drivers, Challenges, and Opportunity/Restraints

12 Competitive Landscape

13 Competitive Analysis

14 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â